INTERNATIONAL PCD REGISTRY
The international PCD Registry (CinicalTrials.gov NCT02419365), coordinated by Prof. Dr. Heymut Omran, University Hospital of Münster, Germany, aims to facilitate recruitment of patients for clinical studies and to provide data for epidemiological research. Data on family history, symptomatology, socio economic background, clinical manifestations, disease course, treatments, outcomes and natural history, as well as diagnostic data are collected. Patient data are continuously contributed by participating centers. For participation in the International PCD Registry the centers need to meet necessary legal and ethical requirements, which are depending on national conditions. The International PCD Registry is registered in the European Rare Disease Registries Infrastructure (https://eu-rd-platform.jrc.ec.europa.eu/erdri_en).
For more information please visit: https://www.pcdregistry.eu/
or contact: PCDregistry.eu@ukmuenster.de; heymut.omran@ukmuenster.de
REGISTRY STUDIES
1. Genotype / Phenotype Correlations
Study coordinators: University Children’s Hospital Muenster (Johanna Raidt, Heymut Omran & Petra Pennekamp)
contact: johanna.raidt@ukmuenster.de
2. Correlation between genotype and lung function of genetically confirmed PCD individuals in an international cohort (Registration (ClinicalTrails.gov): NCT04717005)
Study coordinators: University Children’s Hospital Muenster (Johanna Raidt & Heymut Omran), Copenhagen University Hospital (Kim G. Nielsen)
contact: johanna.raidt@ukmuenster.de; Kim.G.Nielsen@regionh.dk
3. Correlation between nasal NO levels and distinct PCD genotypes (e.g. course of clinical manifestations, diagnostics, lung function, etc.)
Study coordinators: University Medical Center Amsterdam (Eric G. Haarman); Copenhagen University Hospital (June K Marthin & Kim G. Nielsen); University Children’s Hospital Muenster (Johanna Raidt & Heymut Omran)
4. Assessment of phenotypic characteristics within sibling-pairs (e.g. diagnostics, clinical data, etc.)
Study coordinators: Medical School, University of Cyprus & Paediatric Pulmonology Unit, Archbishop Makarios III Hospital, Cyprus (Panayiotis Yiallouros & Panayiotis Kouis ); University Children’s Hospital Muenster (Heymut Omran); Copenhagen University Hospital (Kim G. Nielsen)
Contact: kouis.panayiotis@ucy.ac.cy; yiallouros.panayiotis@ucy.ac.cy
5. Incidence of PCD exacerbations over 12 months by age group, gender and chronic pseudomonas colonization status
Study coordinators: University of Cyprus & Archbishop Makarios III Hospital, Cyprus: (Pinelopi Anagnostopoulou & Panayiotis Yiallouros); University Children’s Hospital Muenster (Heymut Omran); Copenhagen University Hospital (Kim G. Nielsen)
Contact: anagnostopoulou.pinelopi@ucy.ac.cy; yiallouros.panayiotis@ucy.ac.cy
FOR PATIENTS
The aim of PCD registries are to facilitate recruitment of patients with Primary Ciliary Dyskinesia for clinical studies, to provide data for epidemiological research and to determine characteristics of PCD manifestation.
Patients with Primary Ciliary Dyskinesia interested in participating in clinical trials, disease specific registries and research projects can register in the population registry system and will be contacted by experts from the ERN-LUNG CORE.
Contact: ERN-LUNG_PCD-core@ukmuenster.de
ERN-LUNG POPULATION REGISTRY
Within ERN-LUNG, a population registry (https://www.popreg.ern-lung.eu) has been implemented. With this initiative patients interested in participating in clinical trials, disease specific registries and research projects can register in the system and will be contacted by experts from the ERN-LUNG CORE that covers the patient´s disease area such as PCD. This Population Registry is open to all interested patients and not restricted to specific countries.
FOR INDUSTRY
For companies working on natural history/registry data the PCD International Registry can provide respective services:
- Dataset with characterized patients incl.
- Basic Characteristics Data
- Basic PCD Diagnostics including genotype variant
- Nukleotide/cDNA level
- Protein level
- Symptomatology
- Clinical manifestations
- Disease course
- Body Measurements
- Lung Function Assessments
- Organ-related Conditions
- Male Infertility and Semen Analysis
- Microbiological Findings
- Imaging
- Therapy
- Quality of Life QOL-PCD and SNOT-20/22
- Experienced PCD physicians and researchers within PCD-CTN can also assist pharmaceutical companies in building of study designs.
For further information or enquiry please contact Prof. Heymut Omran at heymut.omran@ukmuenster.de